Syros Pharmaceuticals, Inc. - COM NEW (SYRS)

Historical Portfolio Holders from Q3 2022 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q1 2024
20.9 M
Holdings value Q1 2024
$112 M
Value change Q1 2024
+$14.4 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
72
Number of buys Q1 2024
39
Number of sells Q1 2024
-11
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
87184Q206
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 20.9 M $112 M +$14.4 M $5.35 74
2023 Q4 17.8 M $138 M +$54 M $7.79 56
2023 Q3 12.1 M $47.9 M +$6.04 M $3.95 48
2023 Q2 10.6 M $33.5 M +$1.18 M $3.15 52
2023 Q1 10.3 M $27.5 M -$1.43 M $2.67 52
2022 Q4 10.6 M $37.9 M +$7.58 M $3.59 51
2022 Q3 8.18 M $52.7 M +$52.7 M $6.44 38